Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | ||
---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||
Cost of Revenue | |||||||||
Gross Profit | |||||||||
Gross Profit Margin (%) | |||||||||
R&D Expense | |||||||||
SG&A Expense | |||||||||
Total Operating Expenses | |||||||||
Operating Income or Loss | |||||||||
Operating Margin (%) | |||||||||
Interest Expense | |||||||||
Total Other Income/Expenses | |||||||||
Income Before Tax | |||||||||
Income Tax Expense | |||||||||
Income from Continuing Ops. | |||||||||
Net Income | |||||||||
Net Profit Margin (%) | |||||||||
Net Income Available to Common Shareholders | |||||||||
Basic EPS | |||||||||
Diluted EPS | |||||||||
Basic Average Shares | |||||||||
Diluted Average Shares |
Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||
Cost of Revenue | |||||||||||||||
Gross Profit | |||||||||||||||
Gross Profit Margin (%) | |||||||||||||||
R&D Expense | |||||||||||||||
SG&A Expense | |||||||||||||||
Total Operating Expenses | |||||||||||||||
Operating Income or Loss | |||||||||||||||
Operating Margin (%) | |||||||||||||||
Interest Expense | |||||||||||||||
Total Other Income/Expenses | |||||||||||||||
Income Before Tax | |||||||||||||||
Income Tax Expense | |||||||||||||||
Income from Continuing Ops. | |||||||||||||||
Net Income | |||||||||||||||
Net Profit Margin (%) | |||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||
Basic EPS | |||||||||||||||
Diluted EPS | |||||||||||||||
Basic Average Shares | |||||||||||||||
Diluted Average Shares |
Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | ||
---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||
Cash & Cash Equivalents | |||||||||
Marketable Securities | |||||||||
Receivables | |||||||||
Inventories | |||||||||
Other Current Assets | |||||||||
Total Current Assets | |||||||||
Non-Current Assets | |||||||||
Marketable Securities | |||||||||
PPE Net | |||||||||
Intangibles inc. Goodwill | |||||||||
Other Non-Current Assets | |||||||||
Total Non-Current Assets | |||||||||
Total Assets | |||||||||
Current Liabilities | |||||||||
Accounts Payable | |||||||||
Deferred Revenues | |||||||||
Debt, Current | |||||||||
Accrued Liabilities | |||||||||
Other Current Liabilities | |||||||||
Total Current Liabilities | |||||||||
Non-Current Liabilities | |||||||||
Deferred Revenues | |||||||||
Debt, Non-Current | |||||||||
Other Non-Current Liabilities | |||||||||
Total Non-Current Liabilities | |||||||||
Total Liabilities | |||||||||
Shareholders' Equity | |||||||||
Common Stock | |||||||||
Additional Paid-In Capital | |||||||||
Retained Earnings | |||||||||
Other Shareholders' Equity | |||||||||
Total Shareholders' Equity | |||||||||
Total Liabilities & Shareholders' Equity |
Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||
Cash & Cash Equivalents | |||||||||||||||
Marketable Securities | |||||||||||||||
Receivables | |||||||||||||||
Inventories | |||||||||||||||
Other Current Assets | |||||||||||||||
Total Current Assets | |||||||||||||||
Non-Current Assets | |||||||||||||||
Marketable Securities | |||||||||||||||
PPE Net | |||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||
Other Non-Current Assets | |||||||||||||||
Total Non-Current Assets | |||||||||||||||
Total Assets | |||||||||||||||
Current Liabilities | |||||||||||||||
Accounts Payable | |||||||||||||||
Deferred Revenues | |||||||||||||||
Debt, Current | |||||||||||||||
Accrued Liabilities | |||||||||||||||
Other Current Liabilities | |||||||||||||||
Total Current Liabilities | |||||||||||||||
Non-Current Liabilities | |||||||||||||||
Deferred Revenues | |||||||||||||||
Debt, Non-Current | |||||||||||||||
Other Non-Current Liabilities | |||||||||||||||
Total Non-Current Liabilities | |||||||||||||||
Total Liabilities | |||||||||||||||
Shareholders' Equity | |||||||||||||||
Common Stock | |||||||||||||||
Additional Paid-In Capital | |||||||||||||||
Retained Earnings | |||||||||||||||
Other Shareholders' Equity | |||||||||||||||
Total Shareholders' Equity | |||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | ||
---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||
Net Income | |||||||||
Depreciation & Amortization | |||||||||
Deferred Income Taxes | |||||||||
Stock Based Compensation | |||||||||
Accounts Receivable | |||||||||
Inventory | |||||||||
Accounts Payable | |||||||||
Deferred Revenue | |||||||||
Other Non-Cash | |||||||||
Operating Cash Flow | |||||||||
Cash Flows from Investing Activities | |||||||||
PPE Investments | |||||||||
Net Acquisitions | |||||||||
Purchase of Investments | |||||||||
Sale of Investments | |||||||||
Other Investing Activity | |||||||||
Investing Cash Flow | |||||||||
Cash Flows from Financing Activities | |||||||||
Debt Issued | |||||||||
Proceeds from Debt Repayment | |||||||||
Debt Repayment | |||||||||
Proceeds from Sale of Equity | |||||||||
Equity Repurchased | |||||||||
Dividend Paid | |||||||||
Other Financing Activity | |||||||||
Financing Cash Flow | |||||||||
Cash Position | |||||||||
Beginning Cash Position | |||||||||
End Cash Position | |||||||||
Change in Cash | |||||||||
Free Cash Flow | |||||||||
Operating Cash Flow | |||||||||
Capital Expenditure | |||||||||
Free Cash Flow |
Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||
Net Income | |||||||||||||||
Depreciation & Amortization | |||||||||||||||
Deferred Income Taxes | |||||||||||||||
Stock Based Compensation | |||||||||||||||
Accounts Receivable | |||||||||||||||
Inventory | |||||||||||||||
Accounts Payable | |||||||||||||||
Deferred Revenue | |||||||||||||||
Other Non-Cash | |||||||||||||||
Operating Cash Flow | |||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||
PPE Investments | |||||||||||||||
Net Acquisitions | |||||||||||||||
Purchase of Investments | |||||||||||||||
Sale of Investments | |||||||||||||||
Other Investing Activity | |||||||||||||||
Investing Cash Flow | |||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||
Debt Issued | |||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||
Debt Repayment | |||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||
Equity Repurchased | |||||||||||||||
Dividend Paid | |||||||||||||||
Other Financing Activity | |||||||||||||||
Financing Cash Flow | |||||||||||||||
Cash Position | |||||||||||||||
Beginning Cash Position | |||||||||||||||
End Cash Position | |||||||||||||||
Change in Cash | |||||||||||||||
Free Cash Flow | |||||||||||||||
Operating Cash Flow | |||||||||||||||
Capital Expenditure | |||||||||||||||
Free Cash Flow |